Side-effects of topical androgenic and anabolic substances and steroids. a short review

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 16, Issue 3, 2007, Pages 117-122

  Wollina, Qwe ^a   Pabst, Friedemann ^a   Schönlebe, Jaqueline ^c   Abdel Naser, Mohammed Badawy ^e   Konrad, Helga ^a   Gruner, Monika ^a   Haroske, Gunter ^a,c   Klemm, Eckardt ^b   Schreiber, Gerhard ^d  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b Department of Oto Rhino Laryngology ^*  (United States)

^c Institute of Pathology Georg Schmorl   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Adverse effects; Anabolic androgenic steroids; Substances

Indexed keywords

AKNE MYCIN; AKNEMYCIN PLUS; ANABOLIC AGENT; ANDROFEME; ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIOL; CLENBUTEROL; METHYLTESTOSTERONE; STEROID; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CREAM; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPHONIA; FEMALE; GONADAL DISEASE; GYNECOMASTIA; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; MALE; MALE INFERTILITY; MYALGIA; OVARIECTOMY; PAPULE; SEBORRHEA; SKIN HYPERTROPHY; STRIA; SYMPTOMATOLOGY;

ADMINISTRATION, TOPICAL; ADULT; ANABOLIC AGENTS; ANDROGENS; ANDROSTENOLS; DOPING IN SPORTS; FEMALE; GYNECOMASTIA; HUMANS; INFERTILITY; MALE; MIDDLE AGED; SKIN DISEASES; VIRILISM;

EID: 35448968871     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Monaghan L. Creating "The perfect body": a variable project. Body & Society 1999;5:267-290.
2. Frost L. Theorizing the young woman in the body. Body & Society 2005;11:63-85.
3. Collis N, Elliot LA, Sharpe C, Sharpe DT. Cellulite treatment: a myth or reality: a prospective randomized, controlled trial of two therapies, endermologie and aminophylline cream. Plast Reconstr Surg 1999;104:1110-14.
4. Sainio EL, Rantanen T, Kanerva L Ingredients and safety of cellulite creams. Eur J Dermatol 2000;10:596-603.
5. Korkia P, Stimson GV. Indications of prevalence, practise and effects of anabolic steroid use in Great Britain. Int J Sports Med 1997;18:557-62.
6. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582-9.
7. Baulieu EE. Androgens and aging men. Mol Cell Endocrinol 2002;198:41-9.
8. Essah PA, Wickham III EP, Nunley JR, Nestler JE. Dermatology of androgen-related disorders. Clin Dermatol 2006;24:289-98.
9. Mirrashed F, Sharp JC, Krause V, Morgan J, Tomanek B. Pilot study of dermal and subcutaneous fat structures by MRI in individuals who differ in gender, BMI, and cellulite grading. Skin Res Technol 2004;10:161-8.
10. Querleux B. Magnetic resonance imaging and spectroscopy of skin and subcutis. J Cosmetic Dermatol 2004;3:156-61.
11. Rossi AB, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol 2000;14:251-62.
12. Pierard G, Nizet JL Pierard-Franchimont C. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatol. 2000;22:34-37.
13. Hueber F, Schaefer H, Wepierre J. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacol 1994;7:237-44.
14. Lin S, Xing QF, Chien YW. Transdermal testosterone delivery: comparison between scrotal and nonscrotal delivery systems. Pharm Dev Technol 1999;4:405-14.
15. An NM, Kim DD, Shin YH, Lee CH. Development of a novel soft hydrogel for the transdermal delivery of testosterone. Drug Dev Ind Pharm 2003;29:9-105.
16. Hernandez-Nunez A, Dauden E, Garcia-F-Villata MJ, Rios-Buceta L, Garcia-Diez A. Hirsutism secondary to topical testosterone: report of two cases and review of literature. J Eur Acad Dermatol Venereol 2004;18:208-10.
17. Stoppe G, Krause W. Percutaneous resorption of testosterone, androstendione and estradiol and their effect on serum steroid levels. Z Hautkr 1986;61:1372-6.
18. Bolour S, Braunstein G. Testosterone therapy in women: a review. Int J Impotence Res 2005;17:399-408.
19. Jean Hailes Foundation: http://www.jeanhailes.org.au/health_prof_/ hp_tesLfor_women.htm
20. Johnson CE, Berman JR. The role of androgens in hormone replacement therapy. Expert Opin Pharmacother 2005;6:1815-31.
21. Juhn M. Popular sports supplements and ergogenic acids. Sports Med. 2003;33:921-39.
22. Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32:534-42.
23. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:523-54.
24. Shahidi NT. A review of the chemistry, biological action, and clinical application of anabolic-androgenic steroids. Clin Ther 2001;23:1355-90.
25. Chambo-Filho A, Camargos AF, Pereira FEL. Morphological changes induced by testosterone in the mammary glands of female Wistar rats. Brazilian J Med Biol Res 2005;38:553-8.
26. Hoggerbrugge N, Bull P, de Widt-Levert LM, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol 2003;21:41-5.
27. Santen RJ, Mansel R. Benign breast disorders. New Engl J Med 2005;353:275-85.
28. Greenblatt RB, Samaras C, Vasquez JM, Nezhat C. Fibrocystic disease of the breast. Clin Obstet Gynecol 1982;25:365-71.
29. Calzada L, Torres-Calleja J, Martinez JM, Pedron N. Measurement of androgen and estrogen receptors in breast tissue from subjects with anabolic steroid-dependent gynecomastia. Life Sci 2001;69:1465-9.
30. Babigian A, Silverman RT. Management of gynecomastia due to use of anabolic steroids in body-builders. Plast Reconstr Surg 2001;107:240-2.
31. Spiga L, Gorrini G, Ferraris L, Odaglia G, Frassetto G. Unilateral gynecomastia induced by the use of anabolic steroids. A clinical case report. Minerva Med 1992;83:575-80.
32. Schuppe HC, Recker A, Jung A, Schill WB: Anabolika-Abusus. In: MännerMedizin. Schill WB, Bretzel RG, Weidner W (eds). Elsevier/Urban & Fischer, München Jena 2005: p 308-12.